Sponsors must collect and submit financial disclosure information from each covered clinical investigator (Forms FDA 3454/3455) to allow FDA to assess potential bias.
← Back to Glossary
Glossary Term
21 CFR 54
Regulatory
Also known as: 21 CFR Part 54, financial disclosure rule, investigator financial disclosure
FDA regulations requiring disclosure of clinical investigator financial interests in studies submitted to support FDA marketing applications.
Need IRB review for your study?
Elemental IRB provides fast, transparent ethical oversight for commercial and academic research.